4//SEC Filing
Toernsen Monika Maria 4
Accession 0001209191-22-057891
CIK 0001787297other
Filed
Nov 17, 7:00 PM ET
Accepted
Nov 18, 5:01 PM ET
Size
9.4 KB
Accession
0001209191-22-057891
Insider Transaction Report
Form 4
Toernsen Monika Maria
Chief Commercial Officer
Transactions
- Exercise/Conversion
Common Stock
2022-09-15+5,000→ 5,000 total - Sale
Common Stock
2022-09-19$1.51/sh−1,681$2,539→ 3,319 total - Exercise/Conversion
Restricted Stock Unit
2022-09-15−5,000→ 15,000 totalExp: 2031-07-18→ Common Stock (5,000 underlying)
Footnotes (4)
- [F1]Restricted stock units ("RSUs") convert into common stock on a one-for-one basis.
- [F2]Represents the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of RSUs. These sales are mandated by the Issuer's election under its equity incentive plans to require the satisfaction of a tax withholding obligation to be funded by a "sell to cover" transaction and do not represent discretionary trades by the Reporting Person.
- [F3]Each RSU represents a contingent right to receive one share of Issuer's common stock.
- [F4]1/4 of the RSUs vested on September 15, 2022, and the remainder will vest as to 1/4 of the total award in annual installments thereafter, subject to the Reporting Person's continued service to the Issuer on each vesting date.
Documents
Issuer
Passage BIO, Inc.
CIK 0001787297
Entity typeother
Related Parties
1- filerCIK 0001873385
Filing Metadata
- Form type
- 4
- Filed
- Nov 17, 7:00 PM ET
- Accepted
- Nov 18, 5:01 PM ET
- Size
- 9.4 KB